NRL972 clinical trials
Also written NRL972.
How each study uses NRL972 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- NRL972
- 8
Studies by the year they started
8 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Studies
Open first, then newest update. How each study uses NRL972 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedPhase 2NorgineNCT00794716Written as NRL972How we know
- Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With CirrhosisCompletedPhase 1NorgineNCT00896597Written as NRL972How we know
- Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.CompletedPhase 2NorgineNCT00915057Written as NRL972How we know
- Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.CompletedPhase 3NorgineNCT00794482Written as NRL972How we know
- Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and CloxacillinCompletedPhase 1NorgineNCT00857480Written as NRL972How we know
- Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy VolunteersCompletedPhase 1/2NorgineNCT00856869Written as NRL972How we know
- Clearance of NRL972 in Patients With Cirrhosis and in Healthy VolunteersCompletedPhase 1NorgineNCT00856713Written as NRL972How we know
- Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and CyclosporineCompletedPhase 1NorgineNCT00856752Written as NRL972How we know